Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 769 to 770 of 770 entries
Sorted by: Best Match Show Resources per page
Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Saini S, Narang M, Srivastava S, Shah D.
PMID: 34231474
Turk J Gastroenterol. 2021 May;32(5):443-450. doi: 10.5152/tjg.2021.20679.

BACKGROUND: The objectives of this study were to identify and classify patients with functional abdominal pain disorders (FAPD) into its various subtypes as per the Rome IV criteria and to evaluate the underlying psychological factors and the effect of...

Cite
Saini S, Narang M, Srivastava S, et al. Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option. Turk J Gastroenterol. 2021;32(5):443-450doi: 10.5152/tjg.2021.20679.
Saini, S., Narang, M., Srivastava, S., & Shah, D. (2021). Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 32(5), 443-450. https://doi.org/10.5152/tjg.2021.20679
Saini, Shubhanshu, et al. "Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option." The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology vol. 32,5 (2021): 443-450. doi: https://doi.org/10.5152/tjg.2021.20679
Saini S, Narang M, Srivastava S, Shah D. Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option. Turk J Gastroenterol. 2021 May;32(5):443-450. doi: 10.5152/tjg.2021.20679. PMID: 34231474.
Copy Download .nbib Format: NLM
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.

Journal of asthma and allergy

Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP.
PMID: 34429614
J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021.

BACKGROUND: Subcutaneous immunotherapy (SCIT) has been proven as an effective therapy against some allergens for seasonal allergic rhinitis (SAR) patients unresponsive to intranasal corticosteroids and/or antihistamines but carries risk of systemic allergic reactions. Dupilumab blocks the shared receptor component...

Cite
Corren J, Saini SS, Gagnon R, et al. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. J Asthma Allergy. 2021;14:1045-1063doi: 10.2147/JAA.S318892.
Corren, J., Saini, S. S., Gagnon, R., Moss, M. H., Sussman, G., Jacobs, J., Laws, E., Chung, E. S., Constant, T., Sun, Y., Maloney, J., Hamilton, J. D., Ruddy, M., Wang, C. Q., & O'Brien, M. P. (2021). Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. Journal of asthma and allergy, 141045-1063. https://doi.org/10.2147/JAA.S318892
Corren, Jonathan, et al. "Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial." Journal of asthma and allergy vol. 14 (2021): 1045-1063. doi: https://doi.org/10.2147/JAA.S318892
Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021. PMID: 34429614; PMCID: PMC8379710.
Copy Download .nbib Format: NLM
Showing 769 to 770 of 770 entries